Prosecution Insights
Last updated: April 19, 2026

Caamtech Inc.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
2
Final Rejections
4
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18865881 TRYPTAMINE DERIVATIVES ABDALHAMEED, MANAHIL MIRGHANI ALI 1622 Non-Final OA Nov 14, 2024
18858080 CRYSTALLINE QUATERNARY SALTS OF 4-SUBSTITUTED TRYPTAMINES ANDERSON, JAMES D 1629 Non-Final OA Oct 18, 2024
18352677 COMPOSITIONS CONTAINING KRATOM COMPOUNDS SPAINE, ROBERT FRANKLIN 1655 Non-Final OA Jul 14, 2023
18257639 AMANITA MUSCARIA COMPOUNDS HOFFMAN, SUSAN COE 1655 Non-Final OA Jun 15, 2023
18297370 DIALKYL TRYPTAMINES AND THEIR THERAPEUTIC USES ANDERSON, JAMES D 1629 Final Rejection Apr 07, 2023
18180685 DIALKYL TRYPTAMINES AND THEIR THERAPEUTIC USES ANDERSON, JAMES D 1629 Final Rejection Mar 08, 2023

Managing Caamtech Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month